Long term survival after trimodal therapy in malignant pleural mesothelioma.
暂无分享,去创建一个
[1] Keith Cengel,et al. Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma. , 2012, The Annals of thoracic surgery.
[2] D. Landau,et al. Pleurectomy/Decortication is Superior to Extrapleural Pneumonectomy in the Multimodality Management of Patients with Malignant Pleural Mesothelioma , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[3] J. Peto,et al. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study , 2011, The Lancet. Oncology.
[4] P. V. Van Schil,et al. Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial , 2010, European Respiratory Journal.
[5] J. Peto,et al. The Mesothelioma and Radical Surgery Randomized Controlled Trial: The MARS Feasibility Study , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[6] R. Giudicelli,et al. Is malignant pleural mesothelioma a surgical disease? A review of 83 consecutive extra-pleural pneumonectomies. , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[7] B. McCaughan,et al. Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors. , 2009, The Journal of thoracic and cardiovascular surgery.
[8] V. Mehta,et al. Trimodality therapy for malignant pleural mesothelioma. , 2009, The Annals of thoracic surgery.
[9] M. Millward,et al. Outcome for Patients with Malignant Pleural Mesothelioma Referred for Trimodality Therapy in Western Australia , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[10] C. Obasaju,et al. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] R. Flores. Surgical options in malignant pleural mesothelioma: extrapleural pneumonectomy or pleurectomy/decortication. , 2009, Seminars in thoracic and cardiovascular surgery.
[12] V. Seshan,et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. , 2008, The Journal of thoracic and cardiovascular surgery.
[13] K. Forster,et al. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. , 2007, The Annals of thoracic surgery.
[14] Cindy B. Yeoh,et al. Prognostic Factors in the Treatment of Malignant Pleural Mesothelioma at a Large Tertiary Referral Center , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[15] D. Waller,et al. The pattern of lymph node involvement influences outcome after extrapleural pneumonectomy for malignant mesothelioma. , 2006, The Journal of thoracic and cardiovascular surgery.
[16] V. Rousson,et al. Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[17] S. Supiot,et al. Progrès thérapeutiques récents dans le mésothéliome malin primitif de la plèvre , 2005 .
[18] R. Flores. Induction chemotherapy, extrapleural pneumonectomy, and radiotherapy in the treatment of malignant pleural mesothelioma: the Memorial Sloan-Kettering experience. , 2005, Lung cancer.
[19] M J Price,et al. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050 , 2005, British Journal of Cancer.
[20] P. Jänne,et al. Patterns of failure following surgical resection for malignant pleural mesothelioma. , 2004, Thoracic surgery clinics.
[21] J. Godleski. Role of asbestos in etiology of malignant pleural mesothelioma. , 2004, Thoracic surgery clinics.
[22] M. Pistolesi,et al. Malignant pleural mesothelioma: update, current management, and newer therapeutic strategies. , 2004, Chest.
[23] T. Treasure,et al. Pleural mesothelioma: little evidence, still time to do trials , 2004, The Lancet.
[24] R. Stahel,et al. Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] W. Richards,et al. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. , 2004, The Journal of thoracic and cardiovascular surgery.
[26] K. O'Byrne,et al. The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma. , 2004, The Annals of thoracic surgery.
[27] Y. Maehara,et al. Multimodal treatment for resectable epithelial type malignant pleural mesothelioma , 2004, World journal of surgical oncology.
[28] J. Peto,et al. Radical surgery for mesothelioma , 2004, BMJ : British Medical Journal.
[29] J. Miller,et al. Survival after conservative (palliative) management of pleural malignant mesothelioma , 2001, Journal of surgical oncology.
[30] D. Sugarbaker,et al. Extrapleural pneumonectomy in the treatment of malignant pleural mesothelioma. , 1992, The Annals of thoracic surgery.
[31] E. Butchart,et al. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. , 1976, Thorax.
[32] A. Bezjak,et al. Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma. , 2007, The Journal of thoracic and cardiovascular surgery.
[33] S. Neragi-Miandoab. Multimodality approach in management of malignant pleural mesothelioma. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[34] M. Mahé,et al. [Recent progress in treatment of malignant pleural mesothelioma]. , 2005, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.
[35] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[36] W. Richards,et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. , 1999, The Journal of thoracic and cardiovascular surgery.